Casdin Partners Master Fund, L.P. - 11 Aug 2025 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role
10%+ Owner
Signature
Casdin Partners Master Fund, LP, By: Casdin Partners GP, LLC,, its General Partner, By: /s/ Eli Casdin, Managing Member
Issuer symbol
BLFS
Transactions as of
11 Aug 2025
Net transactions value
-$11,300,000
Form type
4
Filing time
13 Aug 2025, 18:43:14 UTC
Previous filing
12 Jun 2025
Next filing
15 Aug 2025
SEC
View on sec.gov

Reporting Owners (4)

Name Relationship Address Signature Signature date CIK
Casdin Partners Master Fund, L.P. 10%+ Owner 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK Casdin Partners Master Fund, LP, By: Casdin Partners GP, LLC,, its General Partner, By: /s/ Eli Casdin, Managing Member 13 Aug 2025 0001534265
Casdin Capital, LLC 10%+ Owner 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK Casdin Capital LLC, By: /s/ Eli Casdin, Managing Member 13 Aug 2025 0001534261
Casdin Partners GP, LLC 10%+ Owner 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK Casdin Partners GP LLC, By: /s/ Eli Casdin, Managing Member 13 Aug 2025 0001534260
Casdin Eli 10%+ Owner 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK /s/ Eli Casdin, Eli Casdin 13 Aug 2025 0001534264

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock, par value $0.001 per share Sale $11,300,000 -500,000 -6.5% $22.60 7,207,165 11 Aug 2025 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC ("Casdin Capital"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.